Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 1 minute read Pharma Industry News Zydus Lifesciences announces FDA approval for heart failure drug, Ivabradine Tablets Zydus Lifesciences Limited, a significant player in the pharmaceutical industry, has received final approval from the United States… byPallavi MadhirajuDecember 2, 2023